RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
RedHill Biopharma将于明天获得美国专利,编号为11,918,560,标题为 “用于治疗冠状病毒感染的丝氨酸蛋白酶抑制剂”
RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
RedHill Biopharma将于明天获得美国专利,编号为11,918,560,标题为 “用于治疗冠状病毒感染的丝氨酸蛋白酶抑制剂”
使用浏览器的分享功能,分享给你的好友吧